Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

Similar articles for PubMed (Select 23838177)

1.

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study.

Lavorgna L, Bonavita S, Ippolito D, Lanzillo R, Salemi G, Patti F, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, d'Ambrosio A, Bresciamorra V, Savettieri G, Zappia M, Alfano B, Gallo A, Simone I, Tedeschi G.

Mult Scler. 2014 Feb;20(2):220-6. doi: 10.1177/1352458513494958. Epub 2013 Jul 9.

PMID:
23838177
2.

Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.

Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.

Mult Scler. 2014 Feb;20(2):202-13. doi: 10.1177/1352458513493034. Epub 2013 Jun 26.

PMID:
23804554
3.

A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.

Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.

Ann Neurol. 2010 Mar;67(3):376-83. doi: 10.1002/ana.21906.

PMID:
20373349
4.

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Rudick RA, Lee JC, Nakamura K, Fisher E.

J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.

5.

Clinical and conventional MRI predictors of disability and brain atrophy accumulation in RRMS. A large scale, short-term follow-up study.

Mesaros S, Rocca MA, Sormani MP, Charil A, Comi G, Filippi M.

J Neurol. 2008 Sep;255(9):1378-83. doi: 10.1007/s00415-008-0924-5. Epub 2008 Jul 3.

PMID:
18584233
6.

Brain atrophy and lesion load predict long term disability in multiple sclerosis.

Popescu V, Agosta F, Hulst HE, Sluimer IC, Knol DL, Sormani MP, Enzinger C, Ropele S, Alonso J, Sastre-Garriga J, Rovira A, Montalban X, Bodini B, Ciccarelli O, Khaleeli Z, Chard DT, Matthews L, Palace J, Giorgio A, De Stefano N, Eisele P, Gass A, Polman CH, Uitdehaag BM, Messina MJ, Comi G, Filippi M, Barkhof F, Vrenken H; MAGNIMS Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1082-91. doi: 10.1136/jnnp-2012-304094. Epub 2013 Mar 23.

PMID:
23524331
7.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
8.

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis.

Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, Thompson AJ, Miller DH.

Brain. 2008 Mar;131(Pt 3):808-17. doi: 10.1093/brain/awm329. Epub 2008 Jan 29.

9.

[Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients].

Gaillard N, Fabro-Perray P, Faillie JL, Le Bayon A, Castelnovo G, Dupeyron A, Froger J, Pelissier J, Labauge P.

Rev Neurol (Paris). 2007 Jan;163(1):72-81. French.

PMID:
17304175
10.

Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis.

Giorgio A, Stromillo ML, Bartolozzi ML, Rossi F, Battaglini M, De Leucio A, Guidi L, Maritato P, Portaccio E, Sormani MP, Amato MP, De Stefano N.

Mult Scler. 2014 Feb;20(2):214-9. doi: 10.1177/1352458513494490. Epub 2013 Jul 22.

PMID:
23877971
11.

Brain atrophy at onset and physical disability in multiple sclerosis.

Rojas JI, Patrucco L, Besada C, Bengolea L, Cristiano E.

Arq Neuropsiquiatr. 2012 Oct;70(10):765-8.

12.

CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis.

Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G.

Neurology. 2004 Oct 26;63(8):1439-45.

PMID:
15505162
13.

Magnetization transfer magnetic resonance imaging and clinical changes in patients with relapsing-remitting multiple sclerosis.

Oreja-Guevara C, Charil A, Caputo D, Cavarretta R, Sormani MP, Filippi M.

Arch Neurol. 2006 May;63(5):736-40.

PMID:
16682543
14.

Gray matter atrophy is related to long-term disability in multiple sclerosis.

Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.

Ann Neurol. 2008 Sep;64(3):247-54. doi: 10.1002/ana.21423. Erratum in: Ann Neurol. 2009 Feb;65(2):232.

PMID:
18570297
15.

Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.

Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.

Mult Scler. 2009 Feb;15(2):204-11. doi: 10.1177/1352458508098270. Epub 2008 Nov 5.

PMID:
18987104
16.

Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.

Enzinger C, Fuchs S, Pichler A, Wallner-Blazek M, Khalil M, Langkammer C, Ropele S, Fazekas F.

Mult Scler. 2011 Jun;17(6):695-701. doi: 10.1177/1352458510394454. Epub 2011 Jan 12.

PMID:
21228028
17.

A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.

Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA, Zambito-Marsala S, Moretti R, Bratina A, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M.

J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):773-80.

18.

Low degree of cortical pathology is associated with benign course of multiple sclerosis.

Calabrese M, Favaretto A, Poretto V, Romualdi C, Rinaldi F, Mattisi I, Morra A, Perini P, Gallo P.

Mult Scler. 2013 Jun;19(7):904-11. doi: 10.1177/1352458512463767. Epub 2012 Oct 15.

PMID:
23069877
19.

Predicting short-term disability progression in early multiple sclerosis: added value of MRI parameters.

Minneboo A, Jasperse B, Barkhof F, Uitdehaag BM, Knol DL, de Groot V, Polman CH, Castelijns JA.

J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):917-23. Epub 2007 Dec 12.

PMID:
18077480
20.

3T deep gray matter T2 hypointensity correlates with disability over time in stable relapsing-remitting multiple sclerosis: a 3-year pilot study.

Zhang Y, Metz LM, Yong VW, Mitchell JR.

J Neurol Sci. 2010 Oct 15;297(1-2):76-81. doi: 10.1016/j.jns.2010.07.014. Epub 2010 Aug 12.

PMID:
20708201
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk